DTx Company Leverages Castor's Real-World Evidence Platform In Registry Study

It's well known that not all patients seeking support are inclined to choose medication, often due to concerns about side effects or personal preferences. A leading digital therapeutics company, pioneering research in behavioral disorders, is committed to offering alternatives to traditional medicinal treatments.

To evaluate the real-world clinical outcomes of patients using their digital products, the company conducted a registry study utilizing Castor’s eClinical technology. This prospective product registry aimed to gain insights into the clinical and demographic characteristics, treatment patterns, outcomes, and healthcare utilization of users in real-world settings. The study was conducted entirely online, using a direct-to-participant model.